Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M309355200 on March 31, 2004 Originally published In Press as doi:10.1074/jbc.M309355200 on January 12, 2004

J. Biol. Chem., Vol. 279, Issue 15, 14488-14495, April 9, 2004
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
279/15/14488    most recent
M309355200v2
M309355200v1
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Harada, K.
Right arrow Articles by Potter, J. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Harada, K.
Right arrow Articles by Potter, J. D.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Familial Hypertrophic Cardiomyopathy Mutations from Different Functional Regions of Troponin T Result in Different Effects on the pH and Ca2+ Sensitivity of Cardiac Muscle Contraction*

Keita Harada{ddagger} and James D. Potter§

From the Department of Molecular and Cellular Pharmacology, University of Miami School of Medicine, Miami, Florida 33101

To understand the molecular function of troponin T (TnT) in the Ca2+ regulation of muscle contraction as well as the molecular pathogenesis of familial hypertrophic cardiomyopathy (FHC), eight FHC-linked TnT mutations, which are located in different functional regions of human cardiac TnT (HCTnT), were produced, and their structural and functional properties were examined. Circular dichroism spectroscopy demonstrated different secondary structures of these TnT mutants. Each of the recombinant HCTnTs was incorporated into porcine skinned fibers along with human cardiac troponin I (HCTnI) and troponin C (HCTnC), and the Ca2+ dependent isometric force development of these troponin-replaced fibers was determined at pH 7.0 and 6.5. All eight mutants altered the contractile properties of skinned cardiac fibers. E244D potentiated the maximum force development without changing Ca2+ sensitivity. In contrast, the other seven mutants increased the Ca2+ sensitivity of force development but not the maximal force. R92L, R92W, and R94L also decreased the change in Ca2+ sensitivity of force development observed on lowering the pH from 7 to 6.5, when compared with wild type TnT. The examination of additional mutants, H91Q and a double mutant H91Q/R92W, suggests that mutations in a region including residues 91–94 in HCTnT can perturb the proper response of cardiac contraction to changes in pH. These results suggest that different regions of TnT may contribute to the pathogenesis of TnT-linked FHC through different mechanisms.


Received for publication, August 25, 2003 , and in revised form, December 22, 2003.

* This work was supported in part by National Institutes of Health Grants HL-42325 and HL-674154. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

{ddagger} Supported by an American Hearth Association postdoctoral fellowship (Florida/Puerto Rico affiliate).

§ To whom correspondence should be addressed: Dept. of Molecular and Cellular Pharmacology, University of Miami School of Medicine, 1600 N. W. 10th Ave., Miami, FL 33136. Tel.: 305-243-5874; Fax: 305-324-6024; E-mail: jdpotter{at}miami.edu.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
D. Dweck, N. Hus, and J. D. Potter
Challenging Current Paradigms Related to Cardiomyopathies: ARE CHANGES IN THE Ca2+ SENSITIVITY OF MYOFILAMENTS CONTAINING CARDIAC TROPONIN C MUTATIONS (G159D AND L29Q) GOOD PREDICTORS OF THE PHENOTYPIC OUTCOMES?
J. Biol. Chem., November 28, 2008; 283(48): 33119 - 33128.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Y. Wen, J. R. Pinto, A. V. Gomes, Y. Xu, Y. Wang, Y. Wang, J. D. Potter, and W. G. L. Kerrick
Functional Consequences of the Human Cardiac Troponin I Hypertrophic Cardiomyopathy Mutation R145G in Transgenic Mice
J. Biol. Chem., July 18, 2008; 283(29): 20484 - 20494.
[Abstract] [Full Text] [PDF]


Home page
Physiol. GenomicsHome page
B. Liang, F. Chung, Y. Qu, D. Pavlov, T. E. Gillis, S. B. Tikunova, J. P. Davis, and G. F. Tibbits
Familial hypertrophic cardiomyopathy-related cardiac troponin C mutation L29Q affects Ca2+ binding and myofilament contractility
Physiol Genomics, April 1, 2008; 33(2): 257 - 266.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
M. Revera, L. van der Merwe, M. Heradien, A. Goosen, V. A. Corfield, P. A. Brink, and J. C. Moolman-Smook
Troponin T and {beta}-myosin mutations have distinct cardiac functional effects in hypertrophic cardiomyopathy patients without hypertrophy
Cardiovasc Res, March 1, 2008; 77(4): 687 - 694.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
S. Morimoto
Sarcomeric proteins and inherited cardiomyopathies
Cardiovasc Res, March 1, 2008; 77(4): 659 - 666.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. R. Pinto, M. S. Parvatiyar, M. A. Jones, J. Liang, and J. D. Potter
A Troponin T Mutation That Causes Infantile Restrictive Cardiomyopathy Increases Ca2+ Sensitivity of Force Development and Impairs the Inhibitory Properties of Troponin
J. Biol. Chem., January 25, 2008; 283(4): 2156 - 2166.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
A. Thawornkaiwong, J. Pantharanontaga, and J. Wattanapermpool
Hypersensitivity of myofilament response to Ca2+ in association with maladaptation of estrogen-deficient heart under diabetes complication
Am J Physiol Regulatory Integrative Comp Physiol, February 1, 2007; 292(2): R844 - R851.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
B. R. Ertz-Berger, H. He, C. Dowell, S. M. Factor, T. E. Haim, S. Nunez, S. D. Schwartz, J. S. Ingwall, and J. C. Tardiff
Changes in the chemical and dynamic properties of cardiac troponin T cause discrete cardiomyopathies in transgenic mice
PNAS, December 13, 2005; 102(50): 18219 - 18224.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
O. M. Hernandez, D. Szczesna-Cordary, B. C. Knollmann, T. Miller, M. Bell, J. Zhao, S. G. Sirenko, Z. Diaz, G. Guzman, Y. Xu, et al.
F110I and R278C Troponin T Mutations That Cause Familial Hypertrophic Cardiomyopathy Affect Muscle Contraction in Transgenic Mice and Reconstituted Human Cardiac Fibers
J. Biol. Chem., November 4, 2005; 280(44): 37183 - 37194.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
G. Venkatraman, A. V. Gomes, W. G. L. Kerrick, and J. D. Potter
Characterization of Troponin T Dilated Cardiomyopathy Mutations in the Fetal Troponin Isoform
J. Biol. Chem., May 6, 2005; 280(18): 17584 - 17592.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2004 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement